Zinc oxide nanoparticles induce photocatalytic cell death in human head and neck squamous cell carcinoma cell lines in vitro

International Journal of Oncology

Volumn 37, Issue 6, 2010, Pages 1583-1590

  Hackenberg, Stephan ^a   Scherzed, Agmal ^a   Kessler, Michael ^a   Froelich, Katrin ^a   Ginzkey, Christian ^a   Koehler, Christian ^a   Burghartz, Marc ^a   Hagen, Rudolf ^a   Kleinsasser, Norbert ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cancer treatment; Head and neck squamous cell carcinoma; Nanoparticles; Photocatalytic effect; UV irradiation; Zinc oxide

Indexed keywords

FLUORESCEIN DIACETATE; LIPOCORTIN 5; NANOPARTICLE; ZINC OXIDE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CYTOTOXICITY; FLOW CYTOMETRY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MOUTH MUCOSA; PHOTOCATALYSIS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET A RADIATION;

CARCINOMA; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOTHERAPY, ADJUVANT; HEAD AND NECK NEOPLASMS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NEOPLASMS, SQUAMOUS CELL; PHOTOCHEMICAL PROCESSES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TIME FACTORS; ULTRAVIOLET RAYS; ZINC OXIDE;

EID: 78649980061     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000812     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu JC and Thun MJ: Cancer statistics 2009. CA Cancer J Clin 59: 225-249, 2009.
2. Parthan A, Posner MR, Brammer C, Beltran P and Jansen JP: Cost utility of docetaxel as induction chemotherapy followed by chemoradiation in locally advanced squamous cell carcinomas of the head and neck. Head Neck 31: 1255-1262, 2009.
3. Marron M, Boffetta P, Zhang ZF, et al: Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol 39: 182-196, 2010.
4. Rogers SJ, Harrington KJ, Rhys-Evans P, O-Charoenrat P and Eccles SA: Biological significance of c-erbB family oncogenes in head and neck cancer. Cancer Metastasis Rev 24: 47-69, 2005.
5. Dias JD, Guse K, Nokisalmi P, Eriksson M, Chen DT, Diaconu I, Tenhunen M, Liikanen I, Grénman R, Savontaus M, Pesonen S, Cerullo V and Hemminki A: Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures. Eur J Cancer 46: 625-635, 2010.
6. Browman GP and Cronin L: Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trials. Semin Oncol 21: 311-319, 1994.
7. Reuter CW, Morgan MA and Eckardt A: Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck. Br J Cancer 96: 408-416, 2007.
8. Emerich DF and Thanos CG: Nanotechnology and medicine. Expert Opin Biol Ther 3: 655-663, 2003.
9. Oberdörster G, Oberdörster E and Oberdörster J: Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113: 823-839, 2005.
10. L'Azou B, Jorly J, On D, Sellier E, Moisan F, Fleury-Feith J, Cambar J, Brochard P and Ohayon-Courtès C: In vitro effects of nanoparticles on renal cells. Part Fibre Toxicol 19: 22, 2008.
11. Colvin V: The potential environmental impacts on engineered nanomaterials. Nature Biotechnol 21: 1166-1170, 2003.
12. Oberdörster E: Manufactured nanomaterials (Fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ. Health Perspect 112: 1058-1062, 2004.
13. Veranth JM, Kaser EG, Veranth MM, Koch M and Yost GS: Cytokine responses of human lung cells (BEAS-2B) treated with micron-sized and nanoparticles of metal oxides compared to soil dusts. Part Fibre Toxicol 27: 2, 2007.
14. 2 and ZnO. Chemosphere 41: 1193-1197, 2000.
15. Theogaraj E, Riley S, Hughes L, Maier M and Kirkland D: An investigation of the photo-clastogenic potential of ultrafine titanium dioxide particles. Mutat Res 634: 205-219, 2007.
16. 2 nanoparticles on Ls-174-t human colon carcinoma cells. World J Gastroenterol 10: 3191-3193, 2004.
17. 2 nanoparticles for photocatalytic cancer-cell treatment. Small 3: 850-853, 2007.
18. Li D and Haneda H: Morphologies of zinc oxide particles and their effects on photocatalysis. Chemosphere 51: 129-137, 2003.
19. Bihari P, Vippola M, Schultes S, Praetner M, Khandoga AG, Reichel CA, Coester C, Tuomi T, Rehberg M and Krombach F: Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part Fibre Toxicol 6: 14, 2008.
20. Zenner HP, Lehner W and Herrmann IF: Establishment of carcinoma cell lines from larynx and submandibular gland. Arch Otorhinolaryngol 225: 269-277, 1979.
21. Balló H, Koldovky P, Hoffmann T, Balz V, Hildebrandt B, Gerharz CD and Bier H: Establishment and characterization of four cell lines derived from human head and neck squamous cell carcinomas for an autologous tumor-fibroblast in vitro model. Anticancer Res 19: 3827-3836, 1999.
22. Schmidt M, Polednik C, Gruensfelder P, Roller J and Hagen R: The effects of PC-Spes on chemosensitive and chemoresistant head and neck cancer cells and primary mucosal keratinocytes. Oncol Rep 21: 1297-1305, 2009.
23. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
24. Majno G and Joris I: Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol 146: 3-15, 1995.
25. Wagenblast J, Baghi M, Arnoldner C, Bisdas S, Gstöttner W, May A, Knecht R and Hambek M: Effects of combination treatment of bortezomib and dexamethasone in SCCHN cell lines depend on tumor cell specificity. Oncol Rep 20: 1207-1211, 2008.
26. 2 powder. Electrochimica Acta 38: 153-157, 1993.
27. Guo D, Wu C, Jiang H, Li Q, Wang X and Chen B: Synergistic cytotoxic effect of different sized ZnO nanoparticles and daunorubicin against leukaemia cancer cells under UV irradiation. J Photochem Photobiol B 93: 119-126, 2008.
28. Camerin M, Magaraggia M, Soncin M, Jori G, Moreno M, Chambrier I, Cook MJ and Russell DA: The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma. Eur J Cancer (In press).
29. Hackenberg S, Friehs G, Froelich K, Ginzkey C, Koehler C, Scherzed A, Burghartz M, Hagen R and Kleinsasser N: Intracellular distribution, geno- and cytotoxic effects of nanosized titanium dioxide particles in the anatase crystal phase on human nasal mucosa cells. Toxicol Lett 195: 9-14, 2010.
30. Geiser M, Rothen-Rutishauser B, Kapp N, Schuerch S, Kreyling W, Schulz H, Semmler M, Im Hof V, Heyder J and Gehr P: Ultrafine particles cross cellular membranes by non-phagocytic mechanism in lungs and in cultured cells. Environ Health Perspect 113: 1555-1560, 2005.
31. Constantin C, Neagu M, Ion RM, Gherghiceanu M and Stavaru C: Fullerene-porphyrin nanostructures in photodynamic therapy. Nanomedicine 5: 307-317, 2010.
32. Oo MKK, Yang X, Du H and Wang H: 5-aminolevulinic acid-conjugated gold nanoparticles for photodynamic therapy of cancer. Nanomedicine 3: 777-786, 2008.